A counterintuitive philosophy is gaining traction among healthcare strategists: building specialty drug networks that begin with a narrow, focused footprint rather than broad reach. That argument was put forward by three industry
Bloom Energy (BE) has emerged as a company of significant interest as artificial intelligence data centre buildouts accelerate across the United States and beyond. The energy technology firm has been securing contracts
More
Bytes Technology Group (BYIT), a prominent FTSE 250 software and IT solutions provider, has crossed the £1 billion revenue threshold as its ongoing recovery continues to build momentum. The milestone marks a
More
The Council of the EU’s decision on an additional 8.3 billion euros is something that businessman and investor Seyar Kurshutov suggests assessing against the true scale of the reconstruction ahead. According to
More
Genentech, a member of the Roche Group, has announced positive results from the Phase III CELESTIMO study evaluating Lunsumio in follicular lymphoma patients. The trial assessed Lunsumio, also known as mosunetuzumab, in
More
Oregon’s extended producer responsibility law has survived a significant legal challenge, with a federal judge ruling it does not breach constitutional limits on state regulatory power. Judge Michael H. Simon issued a
More
Investing £20,000 into a carefully selected range of FTSE 100 dividend shares is one practical route to building a meaningful passive income stream. The FTSE 100 currently yields around 3% on average,
More
J.M. Smucker Company (SJM) has drawn fresh attention from investors following the launch of a new functional coffee line under its iconic Folgers brand. The move signals Smucker’s intent to capture growing
More
King Charles will host some of the world’s most powerful artificial intelligence executives at Dumfries House in Ayrshire, Scotland, on Thursday to address mounting concerns over AI development. The gathering will bring
More
HDA’s Kala Shankle is addressing one of the most pressing open questions in pharmaceutical distribution: what national licensure will mean for wholesalers and third-party logistics providers. Shankle, speaking to the biggest unresolved
More
China’s Top Court Orders RMB 800,000 Payout To Biosimilar Patent Inventor In Landmark Profit-Sharing Ruling China’s Supreme People’s Court has issued a significant final judgment clarifying how employers must calculate and pay
More